These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 11966782)

  • 1. Impact of HLA-compatibilities in patients undergoing liver transplantation for HBV-cirrhosis.
    Neumann UP; Langrehr JM; Naumann U; Lang M; Rayes N; Steinmüller T; Radtke C; Neuhaus P
    Clin Transplant; 2002 Apr; 16(2):122-9. PubMed ID: 11966782
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of human leukocyte antigen matching in liver transplantation.
    Neumann UP; Guckelberger O; Langrehr JM; Lang M; Schmitz V; Theruvath T; Schonemann C; Menzel S; Klupp J; Neuhaus P
    Transplantation; 2003 Jan; 75(1):132-7. PubMed ID: 12544885
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New era of liver transplantation for hepatitis B: a 17-year single-center experience.
    Anselmo DM; Ghobrial RM; Jung LC; Weaver M; Cao C; Saab S; Kunder G; Chen PW; Farmer DG; Yersiz H; Baquerizo A; Geevarghese S; Han SH; Goldstein L; Holt CD; Gornbein JA; Busuttil RW
    Ann Surg; 2002 May; 235(5):611-9; discussion 619-20. PubMed ID: 11981206
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of anti-hepatitis Bc-positive grafts on the outcome of liver transplantation for HBV-related cirrhosis.
    Joya-Vazquez PP; Dodson FS; Dvorchik I; Gray E; Chesky A; Demetris AJ; Shakil O; Fung JJ; Vargas HE
    Transplantation; 2002 May; 73(10):1598-602. PubMed ID: 12042646
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatitis viruses and liver transplantation.
    Samuel D; Feray C; Bismuth H
    J Gastroenterol Hepatol; 1997 Oct; 12(9-10):S335-41. PubMed ID: 9407355
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recurrence of hepatocellular carcinoma and hepatitis B reinfection in hepatitis B surface antigen-positive patients after liver transplantation.
    Saab S; Yeganeh M; Nguyen K; Durazo F; Han S; Yersiz H; Farmer DG; Goldstein LI; Tong MJ; Busuttil RW
    Liver Transpl; 2009 Nov; 15(11):1525-34. PubMed ID: 19877207
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Effect of donor/recipient HLA-B match on transplant survival in patients with liver transplants with HBV cirrhosis].
    Neumann UP; Langrehr JM; Blasczyk R; Lang M; Bechstein WO; Neuhaus P
    Langenbecks Arch Chir Suppl Kongressbd; 1998; 115(Suppl I):367-70. PubMed ID: 14518277
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lamivudine prophylaxis of liver allograft HBV reinfection in HBV related cirrhotic patients after liver transplantation.
    Lu SC; Yan LN; Li B; Wen TF; Zhao JC; Cheng NS; Liu C; Liu J; Wang XB; Li XD; Qin S; Zhao LS; Lei BJ; Zhang XH
    Hepatobiliary Pancreat Dis Int; 2004 Feb; 3(1):26-32. PubMed ID: 14969833
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Liver transplantation in HBsAg-positive HBV-DNA--negative cirrhotics: immunoprophylaxis and long-term outcome.
    Grazi GL; Mazziotti A; Sama C; Jovine E; Stefanini F; Paladini R; Rossi R; Cavallari A
    Liver Transpl Surg; 1996 Nov; 2(6):418-25. PubMed ID: 9346687
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Survival after liver transplantation for chronic hepatitis B using reduced immunosuppression.
    Gish RG; Keeffe EB; Lim J; Brooks LJ; Esquivel CO
    J Hepatol; 1995 Mar; 22(3):257-62. PubMed ID: 7608474
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of Human Leukocyte Antigen Compatibility in Graft Outcomes After Living Donor Liver Transplantation.
    Shin M; Kim JM; Kwon CH; Kim SJ; Joh JW
    Transplant Proc; 2016 May; 48(4):1123-9. PubMed ID: 27320571
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [A clinicopathologic study on complications of orthotopic liver transplantation in 54 patients with chronic hepatitis B virus infection].
    Pei F; Zheng J; Du J; Zhong HH; Yang JP
    Beijing Da Xue Xue Bao Yi Xue Ban; 2008 Aug; 40(4):408-14. PubMed ID: 18677390
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of human leukocyte antigen matching on hepatitis B virus recurrence after liver transplantation.
    Zhao H; Hu JH; Zhou L; Xu X; Wu J; Meng XQ; Fan J; Ma WH
    Hepatobiliary Pancreat Dis Int; 2010 Apr; 9(2):139-43. PubMed ID: 20382583
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of donor/recipient HLA-matching on outcome and recurrence of hepatitis C after liver transplantation.
    Langrehr JM; Puhl G; Bahra M; Schmeding M; Spinelli A; Berg T; Schönemann C; Krenn V; Neuhaus P; Neumann UP
    Liver Transpl; 2006 Apr; 12(4):644-51. PubMed ID: 16555324
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatitis B virus quasispecies evolution after liver transplantation in patients under long-term lamivudine prophylaxis with or without hepatitis B immune globulin.
    Buti M; Tabernero D; Mas A; Homs M; Prieto M; Rodríguez-Frías F; Casafont F; Casillas R; González A; Miras M; Herrero JI; Castells L; Esteban R
    Transpl Infect Dis; 2015 Apr; 17(2):208-20. PubMed ID: 25641570
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Response to an experimental HBV vaccine permits withdrawal of HBIg prophylaxis in fulminant and selected chronic HBV-infected liver graft recipients.
    Stärkel P; Stoffel M; Lerut J; Horsmans Y
    Liver Transpl; 2005 Oct; 11(10):1228-34. PubMed ID: 16184571
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term follow-up of hepatitis B virus-infected recipients after orthotopic liver transplantation.
    König V; Hopf U; Neuhaus P; Bauditz J; Schmidt CA; Blumhardt G; Bechstein WO; Neuhaus R; Lobeck H
    Transplantation; 1994 Sep; 58(5):553-9. PubMed ID: 8091481
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Liver transplantation and HBsAg-positive postnecrotic cirrhosis: adequate immunoprophylaxis and delta virus co-infection as the significant determinants of long-term prognosis.
    Lerut JP; Donataccio M; Ciccarelli O; Roggen F; Jamart J; Laterre PF; Cornu C; Mazza D; Hanique G; Rahier J; Geubel AP; Otte JB
    J Hepatol; 1999 Apr; 30(4):706-14. PubMed ID: 10207814
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An efficacy and cost-effectiveness analysis of combination hepatitis B immune globulin and lamivudine to prevent recurrent hepatitis B after orthotopic liver transplantation compared with hepatitis B immune globulin monotherapy.
    Han SH; Ofman J; Holt C; King K; Kunder G; Chen P; Dawson S; Goldstein L; Yersiz H; Farmer DG; Ghobrial RM; Busuttil RW; Martin P
    Liver Transpl; 2000 Nov; 6(6):741-8. PubMed ID: 11084061
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Experiences with liver transplantation in hepatitis B antigen positive liver cirrhosis].
    Steininger R; Mühlbacher F; Längle F; Gnant M; Sautner T; Götzinger P; Walgram M; Penner E; Radaszkiewicz T
    Wien Klin Wochenschr; 1991; 103(19):573-6. PubMed ID: 1759457
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.